Interim Report January - September 2001

Interim Report 1 January - 30 September 2001 · Net revenue for the third quarter increased strongly to SEK 16.1 million compared with SEK 4.9 million for the corresponding period last year. Net revenue for the interim period increased by 180 per cent to reach SEK 44.7 million (15.9) - Despite increased spendings in research and development, the loss after net financial items for the third quarter decreased to SEK - 3.2 million compared with SEK -7.2 million for the corresponding period last year. The loss after net financial items for the interim period was SEK -25.7 million (-21.2). · The increased pace of expansion resulted in cash flow from current operations and investments for the interim period of SEK -53.4 million (- 24.9). · Liquid funds for the period amounted to SEK 360.0 million · The organisation was strengthened through the appointment of a Chief Financial Officer Lund, 24 October 2001 Svein Mathisen CEO I have briefly examined this interim report for the period 1 January 2001 - 30 September 2001 in accordance with the recommendations issued by the Swedish Institute of Authorised Public Accountants (FAR). A brief examination is very limited compared to a full audit. I have found nothing to indicate that this interim report does not meet the requirements of the stock exchange and annual accounts laws. Lund, 24 October 2001 ERNST & YOUNG AB Åke Stenmo Authorised Public Accountant Any questions regarding this report will be answered by Svein Mathisen, CEO, at +46 (0)46 286 85 67 Website: http://www.bioinvent.com ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/09/25/20030925BIT00520/wkr0002.doc The full report http://www.waymaker.net/bitonline/2003/09/25/20030925BIT00520/wkr0003.pdf The full report